All Posts

Dr. Sebastian Quintremil joined the Glial Pathology lab in November of 2025 for his expertise in cell biology and Alzheimer's disease models. Dr. Quintremil's work will be crucial to advance our understanding of the role of CD44 in Alzheimer's disease, particularly in astrocytes. Welcome.

Dr. Zhou received her Ph.D. in Pharmacology from Tsinghua University and her M.S. in Biostatistics from Columbia University. Her research focuses on developing novel therapeutic strategies for cancer, with a particular emphasis on glioblastoma. Her work centers on targeting cancer-related transcriptional programs. She has extensive experience in designing and evaluating approaches to modulate transcription factor activity, and in assessing their efficacy across multiple cance